SE420730B - Analogiforfarande for framstellning av nya pentacykliska foreningar - Google Patents

Analogiforfarande for framstellning av nya pentacykliska foreningar

Info

Publication number
SE420730B
SE420730B SE7607231A SE7607231A SE420730B SE 420730 B SE420730 B SE 420730B SE 7607231 A SE7607231 A SE 7607231A SE 7607231 A SE7607231 A SE 7607231A SE 420730 B SE420730 B SE 420730B
Authority
SE
Sweden
Prior art keywords
preparation
analogy procedure
pentacyclic compounds
new pentacyclic
new
Prior art date
Application number
SE7607231A
Other languages
English (en)
Swedish (sv)
Other versions
SE7607231L (sv
Inventor
C Thal
R Besselievre
H P Husson
P Potier
Original Assignee
Anvar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anvar filed Critical Anvar
Publication of SE7607231L publication Critical patent/SE7607231L/xx
Publication of SE420730B publication Critical patent/SE420730B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74—Oxygen atoms
    • C07D211/76—Oxygen atoms attached in position 2 or 6

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
SE7607231A 1975-06-25 1976-06-23 Analogiforfarande for framstellning av nya pentacykliska foreningar SE420730B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7519960A FR2315277A1 (fr) 1975-06-25 1975-06-25 Nouveaux derives pentacycliques, leur preparation et les compositions qui les contiennent

Publications (2)

Publication Number Publication Date
SE7607231L SE7607231L (sv) 1976-12-26
SE420730B true SE420730B (sv) 1981-10-26

Family

ID=9157046

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7607231A SE420730B (sv) 1975-06-25 1976-06-23 Analogiforfarande for framstellning av nya pentacykliska foreningar

Country Status (17)

Country Link
US (1) US4138489A (ja)
JP (1) JPS6039679B2 (ja)
AU (1) AU496905B2 (ja)
BE (1) BE843215A (ja)
CH (1) CH616425A5 (ja)
DE (1) DE2627190A1 (ja)
DK (1) DK285576A (ja)
ES (1) ES449209A1 (ja)
FR (1) FR2315277A1 (ja)
GB (1) GB1543807A (ja)
HU (1) HU174882B (ja)
IE (1) IE43138B1 (ja)
IL (1) IL49864A0 (ja)
LU (1) LU75242A1 (ja)
NL (1) NL7606884A (ja)
SE (1) SE420730B (ja)
ZA (1) ZA763779B (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA786426B (en) * 1977-11-25 1979-10-31 Scras New indulo(2,3-a)quinolizidines,preparation and therapeutic use
US4428877A (en) 1978-07-12 1984-01-31 Richter Gedeon Vegyeszeti Gyar Rt. Cis-10-bromo-E-homoeburnanes
JPH0523116Y2 (ja) * 1988-07-29 1993-06-14
FR2648817B1 (fr) * 1989-06-21 1993-02-05 Richter Gedeon Vegyeszet Nouveau derives diester d'octahydro-indolo-(2,3-a)-tetrahydropyranyl (2,3-c) quinolizine racemiques et optiquement actifs et procede pour les preparer
ITRM20010356A1 (it) * 2001-06-21 2002-12-23 Sigma Tau Ind Farmaceuti "5-alogeno derivati della triptamina utili come ligandi del recettore5-ht6 e/o 5-ht7 della serotonina.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3536725A (en) * 1967-11-22 1970-10-27 Miles Lab Cyanoethylated derivatives of 2,3,4,6,7,12-hexahydroindolo(2,3-alpha)-quinolizine
FR2168853B1 (ja) * 1972-01-24 1975-04-25 Centre Etd Ind Pharma

Also Published As

Publication number Publication date
JPS5217488A (en) 1977-02-09
GB1543807A (en) 1979-04-04
IE43138B1 (en) 1980-12-31
BE843215A (fr) 1976-12-21
US4138489A (en) 1979-02-06
IL49864A0 (en) 1976-08-31
LU75242A1 (ja) 1978-01-18
AU496905B2 (en) 1978-11-09
FR2315277A1 (fr) 1977-01-21
NL7606884A (nl) 1976-12-28
ES449209A1 (es) 1977-07-16
HU174882B (hu) 1980-04-28
SE7607231L (sv) 1976-12-26
FR2315277B1 (ja) 1979-08-10
IE43138L (en) 1976-12-25
DK285576A (da) 1976-12-26
ZA763779B (en) 1977-06-29
JPS6039679B2 (ja) 1985-09-06
CH616425A5 (ja) 1980-03-31
DE2627190A1 (de) 1977-01-20
AU1523676A (en) 1978-01-05

Similar Documents

Publication Publication Date Title
SE422941B (sv) Analogiforfarande for framstellning av tetracykliska pyrido-bensazepinforeningar
SE433208B (sv) Forfarande for framstellning av fenoletrar
SE7513571L (sv) Forfarande for framstellning av nya substituerade pyridiner
SE434057B (sv) Forfarande for framstellning av nya rifamycinforeningar
DK146205C (da) Analogifremgangsmaade til fremstilling af 8alfa-ergolin-i-derivater
SE7605139L (sv) Forfarande for framstellning av vattenupptagande cellulosaetrar
SE431545B (sv) Forfarande for framstellning av nya 2-substituerade oxazolopyridiner
SE427839B (sv) Analogiforfaranden for framstellning av n-aryl-n-(1-l-4-piperidinyl)-aryl-acetamider
SE432763B (sv) Forfarande for framstellning av nya homoftalimider
NO146058C (no) Analogifremgangsmaate for fremstilling av substituerte benzamider
SE443142B (sv) Forfarande for framstellning av rifamycinforeningar
SE420730B (sv) Analogiforfarande for framstellning av nya pentacykliska foreningar
SE435715B (sv) Forfarande for framstellning av nya penicilliner
SE7606116L (sv) Forfarande for framstellning av 3-fenoxidbensaldehyder
SE427841B (sv) Analogiforfarande for framstellning av tienamycinderivat
SE7606815L (sv) Forfarande for framstellning av nya naftacenderivat
SE7604781L (sv) Forfarande for framstellning av diarylhydroxibutylaminer
SE421793B (sv) Analogiforfarande for framstellning naftyridinsubstituerade pyrrolderivat
SE431655B (sv) Analogiforfaranden for framstellning av nya 9-klorprednisolon-derivat
SE404186B (sv) Forfarande for framstellning av cyklopropanolderivat
SE427840B (sv) Analogiforfarande for framstellning av tienamycinderivat
SE431979B (sv) Forfarande for framstellning av nya omega-aminoalkansyraarylamider
SE446726B (sv) Forfarande for framstellning av 16-metoxiprostaglandiner
SE7610637L (sv) Forfarande for framstellning av 2-alkylindaner
DK142845C (da) Analogifremgangsmaade til fremstilling af imidazolderivater